NTN21277

Enw Cemegol:

(2S, 4R) -1-((S)-2-(3-(2-((5-((4-(3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)) ocsi) pentyl) ocsi) ethoxy) propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)bensyl)pyrrolidine-2-carboxamide

Cod gwenu:

O=C([C@H]1N(C([C@@H](NC(CCOCCOCCCCCOC2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2OC) )=O)C(C)(C)C)=O)C[C@H](O)C1)NCC5=CC=C(C6=C(C)N=CS6)C=C5

Cod InChi:

InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-33(57) 26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64- 40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9- 14,21,23-24,27-28,33,38,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55, 58)(H,51,52,54)/t33-,38+,43-/m1/s1

Allwedd InChi:

NICKHWYZMNLEPJ-TZSMONEZSA-N

Allweddair:

PROTAC 3 yn seiliedig ar Gefitinib; NTN21277; NTN-21277; NTN 21277

Hydoddedd: 

Storio: 

Disgrifiad:

Mae NTN21277, a elwir hefyd yn PROTAC 3 sy'n seiliedig ar Gefitinib yn PROTAC sy'n recriwtio VHL sy'n achosi diraddio mutants EGFR ac EGFR gyda DC50 o 11.7 nM a 22.3 nM ar gyfer cell HCC827 (Exon 19 del) a cell H3258R (L).

Targed: EGFR